Biogened S.A. (WSE:BGD)
Poland flag Poland · Delayed Price · Currency is PLN
19.50
+0.10 (0.52%)
At close: Apr 28, 2026

Biogened Market Cap

Biogened has a market cap or net worth of 47.90 million as of April 29, 2026. Its market cap has decreased by -25.00% in one year.

Market Cap
47.90M
Enterprise Value
65.82M
Revenue
114.04M
Ranking
n/a
PE Ratio
10.36
Stock Price
19.50

Market Cap Chart

Since August 31, 2011, Biogened's market cap has increased from 45.77M to 47.90M, an increase of 4.66%. That is a compound annual growth rate of 0.31%.

History

DateMarket Cap% Change
Apr 28, 202647.90M-9.72%
Dec 30, 202553.06M-6.09%
Dec 30, 202456.50M27.78%
Dec 29, 202344.21M41.73%
Dec 29, 202231.20M47.67%
Dec 30, 202121.12M1.18%
Dec 30, 2020 Pro Pro
Dec 23, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
MakoLab Spólka Akcyjna 48.21M
Prymus 48.00M
Telestrada 48.29M
ORGANIC Farma Zdrowia 47.88M
BioMaxima 48.98M
CDRL S.A. 49.00M
V-Max Spolka Akcyjna 47.12M
Caspar Asset Management 49.31M
Market Cap Rankings